Recommendations made by the PBAC – September 2024 Intracycle meeting

Recommendations made by the Pharmaceutical Benefits Advisory Committee (PBAC) in September 2024 relating to the listing of drugs on the Pharmaceutical Benefits Scheme (PBS).

• September 2024 – PBAC Outcomes (PDF 184KB) – (Word 67KB)
• September 2024 – Programmed cell death protein 1/death ligand 1 (PD-(L)1) inhibitors Outcome Statement (PDF 265KB) – (Word 41KB)